Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 4.48 | -7.93 |
| PEG Ratio (TTM) | -0.15 | 1.63 |
| P/S Ratio (TTM) | 0.88 | 2.52 |
| P/B Ratio (TTM) | 0.68 | 1.64 |
| P/FCF Ratio (TTM) | 13.85 | 10.98 |
| Price to 5YR AVG Earnings Ratio | 6.04 | 5.14 |
| Price to 5YR AVG FCF Ratio | 14.30 | 8.39 |
Profitability (50%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.90% | 7.01% |
| ROE (TTM) | 15.37% | 11.19% |
| Net Profit Margin (TTM) | 19.67% | 17.62% |
| ROIC 5YR AVG | 7.25% | 12.16% |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 15.23% | 150.89% | 90.36% |
| Revenue | 8.94% | 31.46% | 33.92% |
| Net Income | 13.69% | 193.73% | 115.65% |
| Cash Flow | 3.50% | 59,272.09% | 35,558.84% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.61 | 1.74 |
| Quick Ratio (TTM) | 1.54 | 1.56 |
| D/E Ratio (TTM) | 1.00 | 0.66 |
| Interest Coverage (TTM) | 3.02 | 12.30 |
| Piotroski F-Score | 6 | 6 |
| Altman Z-Score | 1.45 | 2.25 |
| LTL to 5YR AVG FCF | 17.20 | 2.91 |
| Shares Outstanding Growth 5YR AVG | 1.77% | 13.14% |